Denial Patterns

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC40-2

DiraChart Clinical Reference
Protected section 2 of 11
← Document menu
Home Care · DiraChart

5.1 “WNL” alone

DiraChart Clinical Reference

Section NavigationPart 2 of 11PreviousNext

5.1 “WNL” alone

What auditors see

A note that documents only “WNL” or “no change” reads as observations any layperson could record. There is no defense to a denial because the note never claimed an RN was required.

Before — does not survive

Endo: WNL. No issues today.

After — survives

Skilled endocrine assessment performed: capillary blood glucose 96 mg/dL, within the ordered parameter of 80–180 mg/dL; no symptoms of hypo- or hyperglycemia. Insulin regimen adherence verified. Injection sites clear; technique accurate. Feet intact; monofilament 10/10 bilaterally. RN-level assessment required to detect glycemic pattern shifts requiring provider-directed regimen adjustment, evaluate for early micro- and macrovascular complications, and identify medication-induced hyperglycemia given concurrent steroid therapy. Continued skilled monitoring indicated.

What changed

  • Specific findings — the glucose value against the ordered parameter, the technique observation, the foot exam, the monofilament score.
  • Skill-justification clause — the subtle changes the RN was monitoring for that a layperson could not detect.
  • Tie to plan — concurrent steroid therapy referenced; ongoing monitoring justified.
Section NavigationPart 2 of 11PreviousNext